Eight new beta-lactam antibiotics and rosaramicin were tested for their activity against penicillin-susceptible and multiply resistant pneumococci. All of the betalactam drugs were 50-to 150-fold less active against the drug-resistant pneumococci when compared with their activity against penicillin-susceptible pneumococci. Rosaramicin activity was similar to that of erythromycin.
against penicillin-susceptible strains.
The drug-resistant organisms were obtained from Robert Austrian shortly after their initial isolation in South Africa. Strains D3, D4, D5, and D7 were originally isolated from patients at King Edward VIII Hospital in Durban, South Africa. Strains B64, B135, B381, and B812 were isolated from patients at Baragwanath Hospital in Johannesburg, South Africa; strains CMR7 and CMR175 were isolated from patients at Isolation Hospital, Johannesburg. All strains were serotype 19A, except strain number B135, which was serotype 6A. The organisms were maintained at -70°C in brain heart infusion broth supplemented with 10% glycerin and 5% lysed horse blood.
Stock solutions of all antibiotics except Nformimidoyl thienamycin were prepared in appropriate diluents and frozen at -70°C until used. N-Formimidoyl thienamycin was prepared freshly each day.
As recommended by Thornsberry and Swenson, the broth microdilution method, utilizing cation-supplemented Mueller-Hinton broth with lysed horse blood, was used for all determinations (4). Briefly, Mueller-Hinton broth was supplemented with 5% lysed horse blood and 25 mg of Mg2" and 50 mg of Ca2" per liter. A 0.05-ml inoculum (2 x 105 colony-forming units per ml) was added to tubes of the supplemented broth which already contained twofold dilutions of the antibiotics. The final concentration was 105 colony-forming units per ml. The plates were placed in an incubator (370C) without added C02 for 18 to 25 h. The antibiotic concentration of the first microtiter well that showed no evidence of growth (i.e., no turbidity) was defmed as the MIC. The minimal bactericidal concentration was obtained by using an MIC-2000 inoculator (Dynatech Corp.) to transfer 0.0015 ml of culture broth to plates containing 5% sheep blood in Mueller-Hinton agar. The antibiotic concentration of the first well that yielded no growth on overnight incubation was defined as the minimal bactericidal concentration. The minimal bactericidal concentration was equal to or one dilution higher than the MIC for 98% of the tests. Therefore, all data are reported as MICs. The control organism was a penicillinsusceptible Staphylococcus aureus strain (ATCC 25923). Table 1 shows the activity of the new betalactam agents and rosaramicin against penicillinsusceptible pneumococci. Cefotaxime, N-formimidoyl thienamycin, and mezlocillin were the most active (MICs, 0.0078 to 0.06 ,ug/ml); piperacillin was only slightly less active. Cefoxitin, cefoperazone, and moxalactam were the least active of the antibiotics tested (MICs, 0.06 to 1.0 ,tg/ml). All test strains were susceptible to rosaramicin (MICs, 0.0078 to 0.06 ,ug/ml).
All of the MAR pneumococci were highly resistant to penicillin (MICs, 2 to 16 .tg/ml), chloramphenicol (MICs, 16 to 32 ,ug/ml) and methicillin (MICs, 16 to 64 ,ug/ml); six of the organisms were highly resistant to tetracycline (MICs, 32 ,ug/ml or greater). Five were resistant to erythromycin (MICs, 4 to 16 ,ug/ml). Rosaramicin was equivalent to erythromycin, i.e., erythromycin-resistant strains were also resistant to rosaramicin (Table 2) . Cefoxitin, cefamandole, and moxalactam lacked significant activity against any of the MAR pneumococci in relationship to achievable serum levels (40, 40, or 80 to 90 ,ug/ml, respectively, 1 h after a 2-g intravascular dose of cefoxitin, cefamandole, or moxalactam) (2, 3) . Cefoperazone, mezlocillin, and piperacillin showed moderate activity against the MAR organisms.
Cefotaxime and N-formimidoyl thienamycin were the most active; all MAR strains had MICs of 1 to 2 ,ug/ml or less (Table 2 ).
In assessing the susceptibility of penicillin-susceptible and MAR pneumococci to the new antibiotics, several points are evident. First, the MAR strains showed increased resistance to all of the beta-lactam drugs. Even the antibiotics that were most active against the MAR organisms (N-formimidoyl thienamycin and cefotaxime) were 50 to 150 times more active against penicillin-susceptible strains. The antibiotics that showed the least activity against the MAR strains were those that were least active against penicillin-susceptible organisms. Second, the relative increase in resistance to the MAR strains was approximately equal for all of the new betalactam antibiotics, i.e., MICs of all the new betalactam drugs against the MAR strains increased by approximately 50-to 150-fold as compared with their activity against penicillin-susceptible strains (Tables 1 and 2 ). The relatively low MICs VOL. 19, 1981 of N-forniimidoyl thienamycin and cefotaxime against MAR pneumococci relate, therefore, to their good initial activity against penicillin-susceptible organisms and not to some unique ability to resist the biochemical changes in the MAR strains that are responsible for increased antibiotic resistance.
